FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1247-1251 April 28, 1994 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Saven, A. PubMed Citation

Last year, a small group of scientists, physicians, and public health experts gathered at Rockefeller University for a one-day workshop to discuss the accelerating spread of bacterial pathogens resistant to antimicrobial agents and whether multiresistant bacteria pose a threat to public health in the United States. This report is based on the conclusions of that workshop.

After a half-century of virtually complete control over microbial disease in the developed countries, the 1990s have brought a worldwide resurgence of bacterial and viral diseases¹. An important factor in this phenomenon is the acquisition of antibiotic-resistance genes by virtually all major bacterial . . . [Full Text of this Article]

The Dimensions of the Problem

Nosocomial Pathogens

Community-Acquired Pathogens

Prospects for the Future

Spread of Resistance Genes and Resistant Clones

Resistance to Antibiotics and Virulence

Infection Control

Development of New Antibacterial Agents

Threats to Public Health in the United States

Recommendations

Awareness of the Problem

Increased Funding for Basic Research

Surveillance

A Fast Track for New Antibacterial Agents

Conclusions

Source Information

The participants in the workshop that formed the basis for this article are listed in the Appendix.
Rockefeller University
New York, NY 10021-6399

References

Appendix

This article has been cited by other articles:

• Choi, S., Isaacs, A., Clements, D., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., DeGrado, W. F. (2009). De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc. Natl. Acad. Sci. USA 106: 6968-6973 [Abstract] [Full Text]  
• Yang, L., Gordon, V. D., Trinkle, D. R., Schmidt, N. W., Davis, M. A., DeVries, C., Som, A., Cronan, J. E. Jr., Tew, G. N., Wong, G. C. L. (2008). Mechanism of a prototypical synthetic membrane-active antimicrobial: Efficient hole-punching via interaction with negative intrinsic curvature lipids. Proc. Natl. Acad. Sci. USA 105: 20595-20600 [Abstract] [Full Text]  
• Lee, S.S., Yau, B., Huang, J. Q, You, J. H S (2008). Determinants of appropriate antibiotic use in the community -- a survey in Sydney and Hong Kong. British Journal of Infection Control 9: 6-9 [Abstract]  
• Erqou, S., Kebede, Y., Mulu, A. (2008). Increased resistance of Streptococcus pneumoniae isolates to antimicrobial drugs, at a referral hospital in north-west Ethiopia. Trop Doct 38: 110-112 [Abstract] [Full Text]  
• Steele, C. M., Brown, R. N., Botzler, R. G. (2005). PREVALENCES OF ZOONOTIC BACTERIA AMONG SEABIRDS IN REHABILITATION CENTERS ALONG THE PACIFIC COAST OF CALIFORNIA AND WASHINGTON, USA. J Wildl Dis 41: 735-744 [Abstract] [Full Text]  
• Kuhl, A., Svenstrup, N., Ladel, C., Otteneder, M., Binas, A., Schiffer, G., Brands, M., Lampe, T., Ziegelbauer, K., Rubsamen-Waigmann, H., Haebich, D., Ehlert, K. (2005). Biological Characterization of Novel Inhibitors of the Gram-Positive DNA Polymerase IIIC Enzyme. Antimicrob. Agents Chemother. 49: 987-995 [Abstract] [Full Text]  
• Butler, M. M., Skow, D. J., Stephenson, R. O., Lyden, P. T., LaMarr, W. A., Foster, K. A. (2002). Low Frequencies of Resistance among Staphylococcus and Enterococcus Species to the Bactericidal DNA Polymerase Inhibitor N3-Hydroxybutyl 6-(3'-Ethyl-4'-Methylanilino) Uracil. Antimicrob. Agents Chemother. 46: 3770-3775 [Abstract] [Full Text]  
• John, M. A., Pletch, C., Hussain, Z. (2002). In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci. J Antimicrob Chemother 50: 933-938 [Abstract] [Full Text]  
• Leibovici, L., Berger, R., Gruenewald, T., Yahav, J., Yehezkelli, Y., Milo, G., Paul, M., Samra, Z., Pitlik, S. D. (2001). Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link. J Antimicrob Chemother 48: 535-540 [Abstract] [Full Text]  
• Wheeler, J. G., Fair, M., Simpson, P. M., Rowlands, L. A., Aitken, M. E., Jacobs, R. F. (2001). Impact of a Waiting Room Videotape Message on Parent Attitudes Toward Pediatric Antibiotic Use. Pediatrics 108: 591-596 [Abstract] [Full Text]  
• Crisostomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C., de Lencastre, H. (2001). The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc. Natl. Acad. Sci. USA 10.1073/pnas.161272898v1 [Abstract] [Full Text]  
• Domenico, P., Baldassarri, L., Schoch, P. E., Kaehler, K., Sasatsu, M., Cunha, B. A. (2001). Activities of Bismuth Thiols against Staphylococci and Staphylococcal Biofilms. Antimicrob. Agents Chemother. 45: 1417-1421 [Abstract] [Full Text]  
• Cercenado, E., Garcia-Garrote, F., Bouza, E. (2001). In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J Antimicrob Chemother 47: 77-81 [Abstract] [Full Text]  
• Houndt, T., Ochman, H. (2000). Long-Term Shifts in Patterns of Antibiotic Resistance in Enteric Bacteria. Appl. Environ. Microbiol. 66: 5406-5409 [Abstract] [Full Text]  
• Corbella, X., Montero, A., Pujol, M., Domínguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., Gudiol, F. (2000). Emergence and Rapid Spread of Carbapenem Resistance during a Large and Sustained Hospital Outbreak of Multiresistant Acinetobacter baumannii. J. Clin. Microbiol. 38: 4086-4095 [Abstract] [Full Text]  
• Jaffe, R. I., Lane, J. D., Albury, S. V., Niemeyer, D. M. (2000). Rapid Extraction from and Direct Identification in Clinical Samples of Methicillin-Resistant Staphylococci Using the PCR. J. Clin. Microbiol. 38: 3407-3412 [Abstract] [Full Text]  
• Daly, J. S., Giehl, T. J., Brown, N. C., Zhi, C., Wright, G. E., Ellison, R. T. III (2000). In Vitro Antimicrobial Activities of Novel Anilinouracils Which Selectively Inhibit DNA Polymerase III of Gram-Positive Bacteria. Antimicrob. Agents Chemother. 44: 2217-2221 [Abstract] [Full Text]  
• Jones, M. E., Sahm, D. F., Martin, N., Scheuring, S., Heisig, P., Thornsberry, C., Köhrer, K., Schmitz, F.-J. (2000). Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season. Antimicrob. Agents Chemother. 44: 462-466 [Abstract] [Full Text]  
• Johnson, J. R., Delavari, P., Azar, M. (1999). Activities of a Nitrofurazone-Containing Urinary Catheter and a Silver Hydrogel Catheter against Multidrug-Resistant Bacteria Characteristic of Catheter-Associated Urinary Tract Infection. Antimicrob. Agents Chemother. 43: 2990-2995 [Abstract] [Full Text]  
• Roger, M., Faucher, M.-C., Forest, P., St-Antoine, P., Coutlée, F. (1999). Evaluation of a vanA-Specific PCR Assay for Detection of Vancomycin-Resistant Enterococcus faecium during a Hospital Outbreak. J. Clin. Microbiol. 37: 3348-3349 [Abstract] [Full Text]  
• Lessard, I. A. D., Walsh, C. T. (1999). VanX, a bacterial D-alanyl-D-alanine dipeptidase: Resistance, immunity, or survival function?. Proc. Natl. Acad. Sci. USA 96: 11028-11032 [Abstract] [Full Text]  
• Tarantino, P. M. Jr., Zhi, C., Wright, G. E., Brown, N. C. (1999). Inhibitors of DNA Polymerase III as Novel Antimicrobial Agents against Gram-Positive Eubacteria. Antimicrob. Agents Chemother. 43: 1982-1987 [Abstract] [Full Text]  
• Leibovici, L., Shraga, I., Andreassen, S., Pauker, S. G, Rothberg, M., Weinberg, J. R, Duerden, B. I, Drickamer, M. A (1999). How do you choose antibiotic treatment? • Commentary: Resist jumping to conclusions • Commentary: A matter of good clinical practice • Commentary: Honesty is the best policy. BMJ 318: 1614-1618 [Full Text]  
• Bauchner, H., Pelton, S. I., Klein, J. O. (1999). Parents, Physicians, and Antibiotic Use. Pediatrics 103: 395-401 [Abstract] [Full Text]  
• Anthonisen, N. R. (1999). Steroids in COPD : The Nearly Eternal Question. Chest 115: 3-4 [Full Text]  
• Mollerach, M., Lopez, R., Garcia, E. (1998). Characterization of the galU Gene of Streptococcus pneumoniae Encoding a Uridine Diphosphoglucose Pyrophosphorylase: A Gene Essential for Capsular Polysaccharide Biosynthesis. JEM 188: 2047-2056 [Abstract] [Full Text]  
• Matsumoto, M., Tamaoka, H., Ishikawa, H., Kikuchi, M. (1998). In Vitro and In Vivo Antibacterial Activities of OPC-20011, a Novel Parenteral Broad-Spectrum 2-Oxaisocephem Antibiotic. Antimicrob. Agents Chemother. 42: 2943-2949 [Abstract] [Full Text]  
• Metlay, J. P., Stafford, R. S., Singer, D. E. (1998). National Trends in the Use of Antibiotics by Primary Care Physicians for Adult Patients With Cough. Arch Intern Med 158: 1813-1818 [Abstract] [Full Text]  
• Paradise, J. L. (1997). Short-Course Antimicrobial Treatment for Acute Otitis Media: Not Best for Infants and Young Children. JAMA 278: 1640-1642 [Abstract]  
• Eppes, S. C., Klein, J. D., Lewis;, L. L., Cantekin;, E. I., Barnett, E. D., Teele, D. W., Klein, J. O., Kharasch, S. J. (1997). Ceftriaxone for Acute Otitis Media. Pediatrics 100: 157-157 [Full Text]  
• Paradise, J. L., Rockette, H. E., Colborn, D. K., Bernard, B. S., Smith, C. G., Kurs-Lasky, M., Janosky, J. E. (1997). Otitis Media in 2253 Pittsburgh-Area Infants: Prevalence and Risk Factors During the First Two Years of Life. Pediatrics 99: 318-333 [Abstract] [Full Text]  
• Gold, H. S., Moellering, R. C. (1996). Antimicrobial-Drug Resistance. NEJM 335: 1445-1453 [Full Text]  
• Davis, J. M., Huycke, M. M., Wells, C. L., Bohnen, J. M. A., Gadaleta, D., Fichtl, R. E., Barie, P. S. (1996). Surgical Infection Society Position on Vancomycin-Resistant Enterococcus. Arch Surg 131: 1061-1068 [Abstract]  
• Lederberg, J. (1996). Infectious Disease--A Threat to Global Health and Security. JAMA 276: 417-419 [Abstract]  
• Feder, N. M. JR, Pond, K. E. (1996). Addition of Rifampin to Cephalexin Therapy for Recalcitrant Staphylococcal Skin Infections An Observation. CLIN PEDIATR 35: 205-208 [Abstract]  
• Tenover, F. C., Hughes, J. M. (1996). The Challenges of Emerging Infectious Diseases: Development and Spread of Multiply-Resistant Bacterial Pathogens. JAMA 275: 300-304 [Abstract]  
• Jones, D. B. (1996). Emerging Antibiotic Resistance: Real and Relative. Arch Ophthalmol 114: 91-92 [Abstract]  
• Alfonso, E. C., Flynn, H. W. Jr (1995). Controversies in Endophthalmitis Prevention: The Risk for Emerging Resistance to Vancomycin. Arch Ophthalmol 113: 1369-1370 [Abstract]  
• Pallares, R., Linares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F., Martin, R., Gudiol, F. (1995). Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, Spain. NEJM 333: 474-480 [Abstract] [Full Text]  
• Tomasz, A. (1995). The Pneumococcus at the Gates. NEJM 333: 514-515 [Full Text]  
• Petersen, E. A., Mandel, R. M. (1995). Infectious Diseases: Old Diseases Return and New Agents Emerge. Arch Intern Med 155: 1571-1572 [Abstract]  
• McCaig, L. F., Hughes, J. M. (1995). Trends in Antimicrobial Drug Prescribing Among Office-Based Physicians in the United States. JAMA 273: 214-219 [Abstract]  
• Bloch, A. B., Onorato, I. M., Castro, K. G., Tomasz, A. (1994). Multiple-Antibiotic-Resistant Bacteria. NEJM 331: 678-679 [Full Text]  
• Murray, B. E. (1994). Can Antibiotic Resistance be Controlled?. NEJM 330: 1229-1230 [Full Text]  
• Crisostomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C., de Lencastre, H. (2001). The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc. Natl. Acad. Sci. USA 98: 9865-9870 [Abstract] [Full Text]